You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
普利製藥(300630.SZ):綜合製藥累計減持212.93萬股
格隆匯 05-20 17:06

格隆匯5月20日丨普利製藥(300630.SZ)公佈,根據公司收到綜合製藥的《關於股份減持計劃實施情況的告知函》,從上次披露進展之日(2020年03月16日)起截至2020年05月19日綜合製藥通過大宗交易共計減持股份約212.93萬股,佔減持計劃預披露公告時的總股本比例0.7558%,同時因公司非公開發行股票導致綜合製藥(香港)有限公司所持股份比例減少0.2442%,合計減少股份佔公司最新總股本的1.0000%,減持計劃尚未實施完畢。

此次減持後,綜合製藥持有股份1907.32萬股,佔總股本比例6.7167%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account